Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Related Donor BMT in Aplastic Anemia
NCT00004323Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Feb 1995
- Modality
- Monoclonal Antibodies, Stem Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Allogeneic Bone Marrow Transplant-Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins-B-cell lymphoma-chronic lymphocytic leukemia in aplastic anemia (2 arms), sponsored by National Center for Research Resources. Primary endpoint: Efficacy of Transplantation. Started Feb 1995; status: completed.
02
Drugs
Allogeneic Bone Marrow Transplant-Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins-B-cell lymphoma-chronic lymphocytic leukemia
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT00004323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004323.